Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Beauty Health ( (SKIN) ).
On October 30, 2025, The Beauty Health Company appointed Dr. Philippe Schaison to its Board of Directors, recognizing his extensive experience in scaling global beauty and aesthetics businesses. Dr. Schaison, who currently serves as CEO of Soltégo, Inc., brings over 20 years of leadership in the aesthetics, biotech, and consumer health industries. His appointment is expected to enhance the company’s strategic direction and accelerate growth, particularly for its Hydrafacial brand.
The most recent analyst rating on (SKIN) stock is a Sell with a $1.50 price target. To see the full list of analyst forecasts on Beauty Health stock, see the SKIN Stock Forecast page.
Spark’s Take on SKIN Stock
According to Spark, TipRanks’ AI Analyst, SKIN is a Underperform.
The overall stock score reflects significant financial and technical challenges. The company’s high leverage and negative profitability weigh heavily on its financial performance. Technical indicators suggest bearish momentum, and the stock’s valuation is unattractive due to ongoing losses. Despite positive developments in the earnings call, these factors dominate the overall assessment.
To see Spark’s full report on SKIN stock, click here.
More about Beauty Health
The Beauty Health Company (NASDAQ: SKIN) operates in the medtech and beauty industry, offering products that enhance skin health and self-confidence. Its flagship brand, Hydrafacial, along with SkinStylus and Keravive, are pioneers in their respective fields, providing personalized skin health solutions for diverse consumers. The company emphasizes mindful business practices to positively impact communities and the planet.
Average Trading Volume: 1,175,967
Technical Sentiment Signal: Strong Sell
Current Market Cap: $181.4M
See more insights into SKIN stock on TipRanks’ Stock Analysis page.